By
Adrianne Appel2023-11-16T19:53:00
A nursing home chain and its owner agreed to pay $45.6 million in entering a consent judgment with the Department of Justice (DOJ) to resolve allegations employees paid kickbacks to doctors who brought patients to them.
Prema Thekkek and the six skilled nursing homes she owned through her company, Paksn, submitted false claims to Medicare, the DOJ alleged in a settlement agreement filed Wednesday in U.S. District Court for the Central District of California.
Thekkek and her facilities violated the Anti-Kickback Statute and the False Claims Act, the DOJ said.
You are not logged in and do not have access to members-only content.
If you are already a registered user or a member, SIGN IN now.
2025-11-19T19:58:00Z By Adrianne Appel
A New Jersey and Midwest nursing home chain, and its former chief executive, must pay more than $146 million each for extensive health care fraud for engaging in widespread fraud related to Medicare and Medicaid.
2024-07-02T14:42:00Z By Adrianne Appel
A home health company operating in Indiana, Ohio, and Texas agreed to pay nearly $4.5 million to settle allegations it filed false claims by giving sports tickets and other kickbacks to assisted living facilities in exchange for referrals.
2024-01-11T21:50:00Z By Adrianne Appel
New Jersey-based clinical laboratory RDx Bioscience and its chief executive officer agreed to pay more than $13 million to the Department of Justice to settle illegal kickback allegations.
2026-02-05T00:55:00Z By Ruth Prickett
Major accountancy firms in France are under investigation for anti-competitive practices. The French competition watchdog embarked on a series of “unannounced inspections” and removed documents relating to audit and reporting on Jan. 13.
2026-02-03T23:22:00Z By Neil Hodge
The European Commission has launched a formal investigation against Elon Musk’s X under the Digital Services Act over fears that its AI tool Grok may be producing and disseminating illegal material.
2026-02-03T22:57:00Z By Adrianne Appel
Three former executives at Archer-Daniels-Midland intentionally misled investors by inflating the performance of the company’s Nutrition unit, the U.S. Securities and Exchange Commission has alleged.
Site powered by Webvision Cloud